Top 50 Medical Device Startup Investors in Asia in October 2024
A list of 50 angel investors and VC (Venture Capital) funds that invest in Medical device startups based in Asia. We rank investors based on the number of investments they made in Medical device companies from Asia. We update this investor list every month.Top 50 Medical Device Startup Investors in Asia in October 2024
Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong in China, and Singapore.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companiesin the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.Since our debut, we have backed over 530 fast-growing and innovative companies. Over 200 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 70 portfolio companies that have achieved unicorn or super unicorn status.
Show more
Investment focus
- Health Care, Biotechnology, Medical
- Series B, Series A, Series C
- China, United States, Hong Kong
Portfolio highlights
- Zhipu AI — Zhipu AI combines large-scale knowledge map built by itself to form a two-wheel-driven artificial intelligence framework through R&D.
- LongBio Pharma — LongBio Pharma is a biotech company that treats patients with an emphasis on complement and allergy diseases.
- Candid Therapeutics — Candid Therapeutics is a biotechnology company that focuses on the treatment of a range of immunological conditions.
Cowin Capital is a private placement equity investment company focusing on investing in a pioneering enterprise on a long-term basis. It has 18 years of experience in capital management, whose capital management scale was among the front rank, which invested more than 300 companies, of which 60 more became public companies, and 150 moresuccessfully exit.The company was successfully listed on NEEQ, with code 832793, as the third listed famous domestic venture capital institution in NEEQ. It is committed to supporting the growth of small and medium enterprises, continue to launch high-quality listed companies in China Capital Market.Cowin Capital was founded in 2000 and is headquartered in Shenzhen, China.
Show more
Investment focus
- Manufacturing, Health Care, Software
- Series A, Series B, Angel
- China, Hong Kong, United States
Portfolio highlights
- Bytetree — Bytetree is a technology company that focuses on providing the one-stop AI data services for data collection, cleaning, labeling, management, and storage for OEMs and autonomous driving solution providers, covering bicycle intelligence. , vehicle-road coordination, and smart cockpit three scenarios.
- Feiduwei — Feiduwei specializes in researching and developing mixed digital and analog circuits, including signal chain and power-related chips.The devices are utilized in automotive electronics, industrial control, consumer electronics, and various other applications.
- Xingchen Optoelectronics — Xingchen Optoelectronics is dedicated to pushing the boundaries of existing laser communication payload solutions and fostering the development of high-speed satellite laser communication networks.
We help founders build enduring companies.
Show more
Investment focus
- Biotechnology, Health Care, Artificial Intelligence
- Series A, Series B, Series C
- China, United States, Australia
Portfolio highlights
- Dongchedi — The company's platform users interests and hobbies and automatically recommends content, information, and vehicle quotations related to new cars and used cars, providing users with knowledge and car industry information.
- Sanshou Technology — Sanshou Technology focuses on researching and developing smart motorcycles.
- RD Technologies — RD Wallet is a licenced Stored Value Facility in Hong Kong. It is the first business-focused, multiple-currency mobile wallet. RD Wallet offers deposits, local and cross-border payments and foreign exchange services for businesses.
CD Capital is a venture capital firm specialized in life sciences and medical technology. They are currently managing both RMB and USD funds with total size of $600M. CD Capital is operated by a professional team with diversified and profound industry backgrounds. They have made over 40 investments with high growth potential and earned a reputationas a premier venture capital firm with main focus on China healthcare industry. With broad network around China and the world, they have been able to seize the global trend, capture investment opportunities as well as help to define the future for China healthcare industry. Ultimately, they strive to grow best-in-class companies and deliver solid financial return to their investors.
Show more
Investment focus
- Health Care, Biotechnology, Medical Device
- Series A, Series B, Seed
- China, United States
Portfolio highlights
- Mol Breeding — Mol Breeding is a biotech firm that focuses on animal and plants molecular breeding technology R&D and services.
- Healingovation — Healingovation is a med-tech company that specializes in the development and manufacturing of surgical robots, intelligent diagnosis and treatment equipment.
- Greenon Biotech — Greenon Biotech specializes in the research, development, production, and promotion of alternative antibiotic preparations for animals, which primarily include bacteriophages, probiotics, plant extracts, novel acid preparations, high-efficiency disinfectants, and so on.
Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong, and Palo Alto.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Series B, Series C
- China, United States, Hong Kong
Portfolio highlights
- ProfoundBio — ProfoundBio is an oncology biotherapeutics company focused on the development of novel antibody-based therapeutics with curative potential for patients with cancer.
- Targeting One — Targeting One is an in-vitro diagnostic product developer.
- Healingovation — Healingovation is a med-tech company that specializes in the development and manufacturing of surgical robots, intelligent diagnosis and treatment equipment.
Zhejiang Haibang Investment Management Co., Ltd. (also referred as "Haibang Capital") is an investment company focusing on venture capital and private equity. It was established in 2011 in Hangzhou. It was founded by Naxin Yao, the CEO of Focused Photonics, Inc (300203), a number of returnee entrepreneurs and experienced investmentprofessionals. In 2011, Haibang Capital launched its first Haibang Fund (formerly called “Haibang Talent Fund”) which was the first venture capital in China helping new returnees to start their own businesses. It is also a fund connect capital and "Thousand Talent Program" in Zhejiang Province. Haibang Capital keeps working on helping enterprises grow rapidly and build leading edge in their industry. In addition to providing capitals, Haibang Capital provides its investee companies with personalized value-added services, helping create both good economic and social benefits.
Show more
Investment focus
- Health Care, Biotechnology, Medical Device
- Series A, Angel, Series B
- China
Portfolio highlights
- MetaLenX — MetaLenX is a technology-based enterprise focusing on the design, manufacture and application of superlenses.
- Zhiwei Technology — Zhiwei Technology provides microporous foam sheets made of polymer supercritical microcellular foaming that are lightweight and durable.
- LYNK Pharmaceuticals — LYNK Pharmaceuticals is a biotech company focusing on the discovery and development of novel medicines to treat oncology, immunology, and inflammatory diseases. The company was founded in 2018 and is headquartered in Hangzhou, Zhejiang, China.
BioTrack Capital is a China-based investment firm.
Show more
Investment focus
- Health Care, Biotechnology, Medical
- Series A, Series B, Seed
- China, United States, Singapore
Portfolio highlights
- Brise Pharma — Brise Pharma operates in the scientific research and technical service industry.
- Shenluo Medical — Shenluo Medical manufactures functional neural implantable medical devices.
- Rona Therapeutics — Rona Therapeutics is a RNA therapeutics platform enabling discovery and development of modular and programmable RNA medicines.
Med-Fine Capital is a venture capital firm focusing on early stage investments in China healthcare industry. The company is headquartered in Shanghai with offices in Beijing and Shenzhen.
Show more
Investment focus
- Health Care, Medical, Biotechnology
- Series A, Seed, Series B
- China, United States
Portfolio highlights
- Rebbeca Med — Rebecca is committed to the application of precision-controlled MEMS radio frequency technology in clinical disease control and rehabilitation. Its core technology comes from the core team's many years of experience and achievements in research and development and productization at the University of California, Fortune 500 medical equipment,and electronic equipment companies. The company cooperated with domestic university research institutes and many top three hospitals in Beijing, Shanghai, and Hangzhou to independently develop micro-radio frequency technology that surpassed similar products in Europe and America. It focuses on delivering innovative medical solutions to the hands of professional caregivers. Rebecca's team possesses technical expertise in micro-devices, RF, and device integration through years of field practice in micro-electronics and clinical innovation.
- Zhuanma Biotech — Zhuanma Biotechnology is a gene editing service provider dedicated to clinically developing effective ultra-small gene editors into genetic therapeutics that are "curable once and for all."
- Phrontline Biopharma — Phrontline Biopharma specializes in the development of ADC to address unmet medical needs in the field of oncology.
IDG Capital is an investment firm that funds early- to growth-stage companies in the technology sector. Today they work with private equity and venture capital fund managers, investment advisors, and business entities from around the world. Their limited partners include many internationally reputable investors, including sovereign wealth funds,pension funds, institutional investors, major charities, university endowments, family offices, and business luminaries.IDG Capital brings a powerful combination of global perspective and local experience to investment management. As long-term value investors, they are highly skilled at mobilizing global resources to address local needs, especially for Inbound and outbound opportunities in China and the rest of Asia. Their highly skilled team has an in-depth understanding of the Chinese market and enjoys close relationships with many influential business leaders.
Show more
Investment focus
- Software, Internet, E-Commerce
- Series A, Series B, Series C
- China, United States, India
Portfolio highlights
- Galaxy Bot — Galaxy Bot is an innovative robotics company that provides intelligent universal service robotic products.
- Sentient — Community-built open AGI
- Chengdu Pukang Biotechnology Co. — Chengdu Pukang Biotechnology Co., Ltd specializes in the development, production, and supply of high-purity single molecular PEG series derivatives, polypeptide long-acting drug side chains, and their intermediates. The company focuses on serving the pharmaceutical industry with a range of chemical supplies that are crucial for drug development andmanufacturing processes. With a professional R&D team, Chengdu Pukang Biotechnology is dedicated to advancing pharmaceutical intermediates technology and providing solutions that meet the evolving needs of the healthcare sector. The company's commitment to research and development is evident in its continuous efforts to innovate and improve its product offerings to support the pharmaceutical industry.
Legend Capital, a subsidiary of Legend Holdings Ltd., started its vintage year in April, 2001 with a mission to become a top-notch and the most respected venture capital investment manager in China.Managing up to US$700 million across four funds, Legend Capital focuses on driving high-growth ventures with operations substantially based in Chinaor on markets related to China.Legend Capital mainly invests in early stage IT companies, specifically, in sectors of network applications and services, outsourcing and professional services, Infrastructure (IC design/key components), and mid-market growth stage companies in the fields of consumer goods, clean technology, health care, equipment manufacturing and modern services.Among over 60 portfolio companies are Joyo.com (acquired by Amazon.com), SinoCom (0299.HK), Solarfun Power (Nasdaq: SOLF), Spreadtrum Communications (Nasdaq: SPRD), China Sunshine Paper (2002.HK), and VanceInfo (NYSE:VIT), Eyang (0117.HK), etc.As an active investor, Legend Capital provides its portfolio companies extensive business resources and tailored services to assist with business development, company image building, and other critical company building activities on Chinese market so as to add value and maximize returns. Legend Capital is proud and thankful that it has the opportunity to blaze a trail with its innovative practice for China's venture capital industry.
Show more
Investment focus
- Health Care, Medical, Biotechnology
- Series B, Series A, Series C
- China, United States, South Korea
Portfolio highlights
- Zhipu AI — Zhipu AI combines large-scale knowledge map built by itself to form a two-wheel-driven artificial intelligence framework through R&D.
- Ensurge Medical — Ensurge Medical is a medical equipment developer, specializing in research, development, production, and sales of intelligent medical products like surgical energy instruments and ultrasonic scalpels.
- Xellar Biosystems — Xellar Biosystems is a wet artificial intelligence biotechnology company that provides analysis of drug testing and treatment.
Shunwei Capital is a venture capital fund that focuses on early to mid-stage investments in local internet industry. It specializes in incubation, startups, early to mid-stage, and growth capital investments. It seeks to invest in the technology, media, telecommunications, high technology, new media, games, internet finance, and rural area internetsectors. Their investors include sovereign wealth funds, fund of funds, university endowment funds, and family offices.Shunwei Capital is a China-based company that was founded in 2011 by Tuck Lye Koh and Lei Jun.
Show more
Investment focus
- Manufacturing, Internet, Software
- Series A, Series B, Series C
- China, India, United States
Portfolio highlights
- Infinigence — Wuwen Core Dome is dedicated to providing AGI computing power solutions based on its large model energy efficiency optimization tools, with the goal of resolving the challenge of efficient and unified deployment of large model algorithms to large computing power chips.
- Mihuo Intelligence — Mihuo Smart is a smart-home and appliance firm.
- Xingmai Innovation — Xingmai Innovation creates, develops, and sells intelligent swimming pool cleaning robots.
Addor Capital offers investment services by financing early stage ventures and holding securities of other companies.
Show more
Investment focus
- Manufacturing, Electronics, Semiconductor
- Series A, Series B, Funding Round
- China, Hong Kong, United States
Portfolio highlights
- Arthur Pharmaceuticals — Arthur Pharmaceuticals is a high-tech innovative pharmaceutical manufacturer.
- Quail Fire Optoelectronics — Quailhuo Photovoltaic is a provider of solar power generation technology, specializing in the design and development of perovskite photovoltaic materials and battery component preparation technology.
- Suzhou Shensai New Materials — Suzhou Shensai New Materials manufacturers environmentally friendly clean foaming materials and other lightweight materials.
Nippon Venture Capital ("NVCC"), established in 1996 as one of the few largest Japanese independent venture capital firms, is destined to undertake the unprecedented task of providing full-range venture capital services in cooperation with major Japanese business leaders and leading companies, which have supported and nurtured various newbusinesses on their own, as well as proactively developing new venture enterprises.
Show more
Investment focus
- Software, Health Care, Information Technology
- Funding Round, Series A, Seed
- Japan, United States
Portfolio highlights
- Yadokari — Yadokari provides various types of Construction & Real Estate related other services.
- Renalys Pharma — Renalys Pharma is a private, late-stage clinical biopharmaceutical firm in Japan dedicated on developing new therapies that address unmet needs in the management of renal illness in Japanese and Asian patients.
- Arsaga Partners — Arsaga Partners, Inc., "develop with the fastest and highest quality" as concept, is a one-stop IT system development company.- All functions necessary for IT system development such as IT strategy consulting, UX/UI consulting, planning, engineering, designing, maintenance and operations are provided through our one-stop solution.- With engineers accounting for over 90% of our company structure we can work directly with our clients. - Our motto is to providing services at a reasonable cost without outsourcing and to bring our Japanese omotenashi spirit to our development services. - We think of Digital transformation (DX) Not as a trendy word, but as IT system development that truly contributes to our clients' business needs.Main Services - One-stop IT System Development Business, Start-up/New IT Business Consulting, Enterprise System/New Business Planning and Development(Digital Transformation/DX), Web System Planning and Development, Application Planning and DevelopmentKey Clients - Nippon Steel Kowa Real Estate Co., Ltd., Mitsubishi Estate, ShionogiV-CUBE, Mizuho Securities, Sciseed inc.
Dalton Venture is a fund management company that specializes in early stage investment and industrial mergers and acquisitions in the field of big health.
Show more
Investment focus
- Health Care, Medical, Medical Device
- Series A, Series B, Angel
- China
Portfolio highlights
- Pharmolix — Pharmolix is a biomedical company that focuses on the R&D and application of large models in the vertical industry of biomedicine.
- Kangyuan Medical — Kangyuan Medical is committed to developing, and manufacturing a new generation of precise and effective blood purification adsorption materials.
- Jichen Biotechnology — Jichen Biotechnology designs, manufactures, supplies, and maintains automation and information equipment systems.
Nissay Capital is a venture capital Company specializing in seed, start-up, growth capital, middle stage, and later stage investment.
Show more
Investment focus
- Health Care, Medical, Internet
- Funding Round, Seed, Series A
- Japan, Ethiopia, United States
Portfolio highlights
- Loglass — Loglass offers corporate intelligence to enhance business management.
- Starley — Starley offers end-to-end development and implementation of artificial intelligence-related products.
- AstroX — AstroX is a private space startup company that develops satellite launch vehicles for space development. It utilizes the rockoon method for developing launch vehicles and small rockets to help clients easily use space.
Apricot Capital is an investment firm focused on investing in companies in the early and growing stages of the healthcare industry, including biopharmaceuticals, life sciences, medical devices, medical services, and diagnostics.Founded in 2015, Apricot Capital consists of more than 20 professionals and consultants with experience in thehealthcare industry. Its professional background includes life sciences, medicine, finance and law.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Seed, Series A, Series B
- China, United States, Hong Kong
Portfolio highlights
- Zhonghe Gene — Zhonghe Gene is a gene technology developer, primarily involved in the research and development of DNA biosynthesis technology.
- Sieran Medical — Sieran Medical is a medical device company that provides precise and intelligent minimally invasive surgical treatment solutions for ophthalmology.
- Simcere Pharma — Founded on 28th March 1995, Simcere swiftly evolved from being a pure distributor of pharmaceutical products to become a leading manufacturer and supplier of drugs in China's rapidly growing pharmaceutical market. Simcere currently operates five GMP-certified manufacturing facilities, two nationwide sales and marketing subsidiaries, a researchand development center and manages over 4,000 employees. They are the first Chinese chemical and biological drug company to list on the New York Stock Exchange with IPO proceeds reaching US$ 261 million.
SZHTI Group is a company that provides asset management and financing services.
Show more
Investment focus
- Manufacturing, Electronics, Semiconductor
- Series A, Angel, Funding Round
- China, United States
Portfolio highlights
- Light Future — Light Future is a complete metal additive manufacturing solutions provider for the industrial market. It is dedicated to speeding up the global industrialization of metal additive manufacturing technology and focuses on all-inclusive solutions for industrial-grade metal additive manufacturing. This will enable additive manufacturing technology tobecome truly inclusive for industrial use.
- Ruibo Automation — Ruibo Automation is a high-tech inventive firm that specializes in Press-Fit pin process automation equipment. It combines independent research and development, manufacturing, and sales.
- Xiaoyao Technology — Xiaoyao Technology is an optoelectronic chip design automation.
Marathon Venture Partners is an international VC fund that focuses on early and growth stage companies in healthcare and Fintech industry.
Show more
Investment focus
- Health Care, Medical, Biotechnology
- Series A, Series B, Angel
- China, Hong Kong, United States
Portfolio highlights
- Natus — Nators specializes in precision motion positioning platforms, mechanical sensors, and nanoscience instruments, the company has developed precision positioning and sensing products for various applications, including optics, microscopy, and nano-level characterization and analysis. With a strong R&D capability and a complete production capacity,the company has become a partner of many domestic laboratories.
- Bingjing Smart — Bingjing Smart is a cardiovascular interventional imaging company. It is an acoustics-based startup that uses imaging as a form of communication and is aiming for the digital medical revolution. It creates specialist digital interventional imaging products for heart and vascular illnesses. It helps in advancement of digital cardiovascularinterventional imaging, leveraging digital to empower the entire process of cardiovascular disease diagnosis and treatment.
- Minglan Shijia — Minglan Shijia focuses on the health of women's whole reproductive cycle and deeply cultivates the field of digital therapy in obstetrics and gynecology.
Taiyu Investment is an investment firm.
Show more
Investment focus
- Medical, Medical Device, Biotechnology
- Series A, Angel, Seed
- China
Portfolio highlights
- Juhai Hengchuang — Juhai Hengchuang is a medical device manufacturer that exclusively sells and manufactures drug testing equipment.
- Rhino Medical — Rhino Medical develops advanced technologies with independent intellectual property rights. The founding team has rich experience in R&D, marketing, and clinical. On the basis of benchmarking imported phacoemulsification instruments and vitrectomy instruments
- St Phi Therapeutics — Yizun Biotechnology is a cutting-edge immune cell therapy company that has developed many unique platform technologies, including solid tumor treatment and allogeneic universal cell therapy.
Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure its first element of the new bio-industry funds 540 million yuan fund size. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greaterdevelopment space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services.Bioventure brought together senior investment professionals team with bio-pharmaceutical industry investment experience, strong fund management, entrepreneurship and venture capital and operating experience in business, have a deep understanding of the domestic and foreign markets, capable of its forward-looking international perspective and extensive The industry has the potential resources to help innovative companies grow rapidly and gain greater success, while giving fund investors bring considerable returns.Suzhou Industrial Park, the core investor BioBay has the country's best medical and pharmaceutical incubator function, use the platform, the project team has great resources and industrial service advantages, Yuan-sheng venture has successfully invested in 20 projects have been cast projects in their own development and follow-up financing, has made outstanding achievements in the industry for all to see, and won the Venture's trust and praise.By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation.
Show more
Investment focus
- Health Care, Medical, Biotechnology
- Series A, Series B, Seed
- China, United States, Taiwan
Portfolio highlights
- Secretech — Secretech is a R&D-driven biotechnology company.Secretechis creates biomarkers and cellular exosomes and is dedicated to the discovery and development of novel biomarkers and cellular exosomes.
- Gachun Biotech — Gachun Biotech is a pharmaceutical intermediates industrialization platform that focuses on APIs, or pharmaceutical intermediates.
- Changsha Morning Shine — Changsha Morning Shine is an innovative pharmaceutical company that specializes in R&D outsourcing, biomedicine, chemical drugs, and biotechnology services.
Goldport Capital is a Shenzhen-based asset management company.
Show more
Investment focus
- Manufacturing, Medical, Biopharma
- Series A, Seed, Angel
- China
Portfolio highlights
- Fast Photonics — Fast Photonics specializes in the development and manufacturing of high-speed optical transceivers. The company offers a range of products designed for various applications in the field of optical communication. With a focus on innovation, Fast Photonics aims to provide solutions that meet the evolving needs of data transmission and communicationnetworks. The company holds ISO certification, emphasizing its commitment to quality and standards in manufacturing processes. Fast Photonics serves as an OEM/ODM/JDM partner, offering customized solutions to meet specific customer requirements. The company's expertise in optical technology makes it a key player in the industry, catering to the demands for faster and more efficient data communication.
- REEM Healthcare — REEM Healthcare is a new type of medical device R&D and manufacturing company focused on the development and production of PHIS tiny particle units (professional, wearable, and implantable), new medical device IoT goods, and the provision of professional smart disease management services.Ruimeng Medical brings together senior experts in medicaldevices, health management, mobile Internet, big data processing, and other fields to form a new medical device R&D and production enterprise dedicated to the R&D and production of PHIS small particle units (professional, wearable, and implantable), new medical device IoT products, and professional intelligent disease management services.
- Ruigu New Materials — Ruigu New Materials is a new energy battery technology developer that specializes in the research, development, and manufacture of new energy battery technology, as well as the research, development, and production of sulfide solid electrolytes.
Mitsubishi UFJ Capital is a venture capital firm focusing on life science, ICT, and high technology investments.
Show more
Investment focus
- Information Technology, Software, Health Care
- Funding Round, Series A, Series B
- Japan, United States, China
Portfolio highlights
- Flucle — Flucle provides company rule building and risk mitigation, cloud advisor, human resource development, training & labor management services.
- Triorb — Triorb is a technology company that specializes in robot mobility development with the help of software and hardware solutions.
- Symbiobe — Symbiobe develops and promotes a resource-recycling material production platform that effectively utilizes natural biomass resources and photosynthetic organisms, which have not been fully exploited in the past, and to update manufacturing around the world to a form that can be passed on to the next generation, thereby making sustainable society...
Shanlan Capital is a professional fund focused on early and growing health care industry investments with offices in Shanghai and Beijing, focusing on biomedical and medical devices (in vitro diagnostics and gene technology, minimally invasive interventions, implantable devices, minimally invasive High-growth segments such as surgical instrumentsand medical robots, and medical services. It has invested in 15 medical star companies such as Guoke Hengtai, Ricky Surgery, Jingyi Medical, Haipulos, Langhe Medical, etc. The core team of Shanlan Capital is the founder of the medical industry listed company, professional financial and strategic investment. Composition of people, in strategy formulation, talent introduction, technology research and development, market camp..
Show more
Investment focus
- Health Care, Medical, Medical Device
- Series A, Series B, Seed
- China
Portfolio highlights
- JH Cispoly — JH Cispoly develops diagnostic technology and equipment for gynecological tumors.
- Better Medtech — Better Medtech is a provider of innovative solutions for urinary and pelvic floor health. Its primary business is the research and development, production, sales, and related services of specialized medical devices, with a focus on creating comprehensive and precise revolutionary products in markets such as benign prostatic hyperplasia, urinaryincontinence, stones, and novel tumour therapies.
- Medtech Technology — Medtech Technology is a firm that develops innovative ophthalmic medical devices.It has developed its own artificial lens production and research technology platform, as well as a technological barrier to high-end artificial lens manufacture.
SND Ventures Group is a venture capital and private equity firm specializing in seed investments.
Show more
Investment focus
- Health Care, Manufacturing, Medical
- Series A, Series B, Angel
- China
Portfolio highlights
- Shenglei Technology — Shenglei Technology manufactures engineering products and offers laser ultrasonic testing services.
- Guancheng Information — Guancheng Information is a competent provider of comprehensive intelligent industrial solutions. It focuses on the medical device and high-technology electronics industries.
- Xinshinuo Semiconductor — Xinshinuo Semiconductor is a domestic semiconductor equipment and technology company.
CDH Investments is an international alternative asset fund manager with over $27 billion of assets under management. CDH Investments was established in 2002 by the former private equity group of China International Capital Corporation and is managed by an experienced team of senior private equity professionals who have worked together for manyyears focusing all their professional time on investing in China. CDH has consistently delivered superior returns relative to industry peers and is well positioned to continue to generate superior returns due to the team's proven investment experience and expertise investing in China.
Show more
Investment focus
- Manufacturing, Health Care, Biotechnology
- Series A, Series B, Series C
- China, United States, Canada
Portfolio highlights
- Yida Technology — SaaS, Data
- Spear Bio — Successive Proximity Extension Amplification Reaction (SPEAR) technology from Spear Bio enables ultra-sensitive biomarker detection using ultra-small samples.
- Weimai Medical — Weimai Medical is an all-inclusive resource for minimally invasive and non-invasive energy medicine solutions.
Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.
Show more
Investment focus
- Medical, Biotechnology, Health Care
- Funding Round, Seed, Series A
- China, United States, United Kingdom
Portfolio highlights
- Zhenyi Yiliao — Zhenyi Yiliao is a medical enterprise focusing on structural heart disease.
- Rhino Medical — Rhino Medical develops advanced technologies with independent intellectual property rights. The founding team has rich experience in R&D, marketing, and clinical. On the basis of benchmarking imported phacoemulsification instruments and vitrectomy instruments
- Cytonus Therapeutics — Cytonus Therapeutics is a biotech company that develops a therapeutic platform designed to treat immune-related disorders. The Cargocyte platform at Cytonus has diverse applications as it can be engineered to target specific tissues and can deliver strategic therapeutic payloads.
NUS Enterprise provides an entrepreneurial and innovative dimension to the National University of Singapore’s core research and educational activities.By encouraging the entrepreneurial spirit, partnering for success, and nurturing future entrepreneurial leaders, NUS Enterprise aims to make a positive impact on Singapore’s economy and beyond.This is done through three key thrusts: entrepreneurship support, industry engagement and partnerships, and experiential education.NUS Enterprise was founded in 2001 and is based in Singapore.
Show more
Investment focus
- Information Technology, Health Care, Software
- Pre-Seed, Grant, Seed
- Singapore, Turkey, United States
Portfolio highlights
- YoRipe — YoRipe helps household to enjoy easy, healthy, and personalized cooking while empowering real time personalized marketing for FMCGs and retailers. The mobile platform brings more efficient marketing and actual shopper behavior insights to brands and stores. YoRipe’s aim is to make managing grocery at home more pleasant and efficient to save timeand money.YoRipe gives recipes for diet, allergies, and cravings. This mobile app also tracks food and send reminders before they expire whenever and wherever.
- Guardara — The most comprehensive negative testing / fuzz testing platform to hunt down bugs and zero-day vulnerabilities.
- Responsible Cyber with IMMUNE — Responsible Cyber Landing Page
Fortune Capital, established in April, 2000, is one of the earliest market-oriented venture capital firms in China. For the past 14 years, Fortune Capital focus its investments on leading companies in four key sectors: TMT (Media oriented), Consumer Goods/Services, Modern Agriculture and Clean Tech.Fortune Capital is ranked among thehighest performing VC/PE firms in China and selected as "Vice President of Venture Capital Committee of IAC," "Vice President of Shenzhen VC Association," "Vice President of Shenzhen Chamber of International Investment & Funding," etc.In addition to providing capitals, Fortune Capital provides its investee companies with personalized value-added services.
Show more
Investment focus
- Manufacturing, Information Technology, Health Care
- Series A, Series B, Series C
- China, Japan, United States
Portfolio highlights
- GZTech — GZTech is a technology company that specializes in the development, production, and sale of advanced industrial lasers and light sources for precision.
- Inspire-Robots — Inspire-Robots provides robot core components as well as intelligent operation solutions. They specialize in the research and development, production, and sales of micro linear actuators and EOAT, which include robotics, biomedical automation, industrial automation, education, scientific research, and other fields.
- Zhongke Ruijian — Zhongke Ruijian is a counterfeit detection platform that aims to empower digital content security by using AI technology to detect false information and forgery tracing for many fields.
Taiyu Investment is an investment firm.
Show more
Investment focus
- Medical, Health Care, Biotechnology
- Series A, Seed, Angel
- China
Portfolio highlights
- Immorna — Immorna specializes in the production of RNA-based therapeutics.
- ChomiX Biotech — ChomiX Biotech will always manage the company's development with a realistic, disciplined, and excellence-driven scientific research mindset. In addition, the company will use cutting-edge technology to solve problems for clients and generate revenue. We can only see the stars if we stay grounded. ChomiX will continue to research and developits own core technology in order to continually maintain its top rank on the track and steer the development of the industry.
- Weixin Medical — Weixin Medical is an innovative medical device platform for women's health.
Oriza Holdings is a Chinese management fund that covers equity, debt financing, and investment since 2007.
Show more
Investment focus
- Health Care, Manufacturing, Biotechnology
- Series A, Series B, Series C
- China, United States, Canada
Portfolio highlights
- Zhongke Jiahe — Zhongke Jiahe develops compilation technology and aspires to build a universal, low-cost, high-performance fundamental software tool chain.
- Xinshi Technology — Xinshi Technology is the developer of semiconductor front-end measurement and testing equipment.
- CATUG Biotechnology — CATUG is focused on the development and application of new biomedical technologies. It provides one-stop CDMO services for the entire industry chain from quality research and clinical application to industrialization. It has R&D centers and industrialization bases in Suzhou and Wuhan.
Qiaojing Capital is an investment firm that invests in the medical, consumer & supply chain financial management industries. Qiao Jing Capital's core operation team has experience in senior management positions in well-known asset management companies at home and abroad. The company's operations fully follow the leading models athome and abroad, and pursue strict risk management and efficient incentive mechanisms.
Show more
Investment focus
- Health Care, Medical, Medical Device
- Series A, Series B, Angel
- China
Portfolio highlights
- Hicicare — Hicicare is a medical technology company that specializes in the development of pan-vascular interventional medical devices.
- Yisheng Microna — Yisheng Microna is an ultrasonic transducer designer and developer, focusing on providing minimally invasive interventional ultrasonography catheters and transducers.
- Elite Technology — Elite Technology is a company that specializes in the development of chromatographic techniques, workstations, and high-performance liquid chromatography equipment for analysis, preparation, and industrial production.
By adopting revolutionary mechanisms, FREES FUND is devoted to change the long-established rules in the venture capital. By leveraging the cutting-edge technologies and resources, FREES FUND aims at investing in great startups and helping them grow into great enterprises that are valuable to our society. We mainly invest in early-stagestartups, and hope to become their first-round institutional investor. Our primary interested areas are broad-sense TMT (Technology, Media, Telecom), B2B and deep technology.
Show more
Investment focus
- Artificial Intelligence, Biotechnology, Medical
- Series A, Seed, Angel
- China, United States, Singapore
Portfolio highlights
- Polycent — Polycent, a technology company with expertise in power technology, industrial control, data intelligence, and FPGA, develops digital power solutions using advanced electrical, sensing, and algorithm technologies, accelerating industrialization and high-quality power system development.
- Dezao Technology — Dezao Technology is an e-commerce transaction provider, mostly involved in the sales of electronic products, mobile phones, and mobile phone accessories.
- Hangkai Microelectronics — Hangkai MicroTech focuses on the research, development, and manufacturing of Mems technology and products, with an emphasis on the demand for domestic sensor substitutes.
Shenzhen EFUNG Investment Management Enterprise L. P. is one of China's earliest institutions investing in professional biomedical industries. Their strong research team and great investment returns made us won 'The Most Pioneering VC Institution” 'The Most Dynamic Pharmaceutical VC Institution in China' and 'The Top Ten VCInstitutions in Shenzhen'. With this influence, EFUNG has drawn a lot of attention from the medical and life science industry. And it is interviewed by Nature, which is the most authoritative science magazine in the world. Over a decade of years, they have been focusing on the medical and health industry, especially the VC and PE investment business of novel drugs and high-end medical devices. The mission of EFUNG is to drive the industrialization of medical researches by capital and to gain rich returns to investors. EFUNG has deeply screened and invested in more than 20 domestic and international premium enterprises, such as Chipscreen Biosciences, Frontier Biotechnologies, Ascentage Pharma, Lifotronic, Aridis Pharmaceuticals, and Centrexion.
Show more
Investment focus
- Biotechnology, Health Care, Pharmaceutical
- Series A, Series B, Series C
- China, United States, India
Portfolio highlights
- Huiguan Biology — Huiguan Biology is a developer of super-resolution microscopes for in vivo drug screening.
- CATUG Biotechnology — CATUG is focused on the development and application of new biomedical technologies. It provides one-stop CDMO services for the entire industry chain from quality research and clinical application to industrialization. It has R&D centers and industrialization bases in Suzhou and Wuhan.
- Pregis New Materials — Pregis New Materials is a cold chain technology company that provides customers with dual carbon and temperature control solutions and materials.
ASBV focuses on early and mid-term venture capital investments.
Show more
Investment focus
- Health Care, Medical, Biotechnology
- Seed, Series A, Angel
- China, Australia, Hong Kong
Portfolio highlights
- Kaiyue Life — Kaiyue Life focuses on small molecule medication research & development for the treatment of human Ras mutant solid tumours.
- Boundary Intelligent Control — Boundary Intelligent is specialized in creating airborne systems, such as flight control systems, that satisfy the needs of civil aircraft, as well as enhancing the ecology of the civil aviation industry and constructing aircraft perception, navigation, decision-making, and planning capabilities.
- Longyue Mechanical and Electrical Technology — Longyue Mechanical and Electrical Technology engaged in technologies, strengthened linkages, and provided commercial aircraft services.
Catalysing smart monies into Singapore-based, early-stage technology startups.
Show more
Investment focus
- Software, Biotechnology, Health Care
- Seed, Series A, Funding Round
- Singapore, United States, Hong Kong
Portfolio highlights
- DiMuto — DiMuto is a platform facilitating collaborative commerce that provides supply chain visibility. They provide global supply chains with a trade technology platform built on 4Ts: Tracking, Tracing, Transparency and Trust – thus demystifying global trade and enabling collaborative commerce. The DiMuto Track & Trace blockchain platform createsend-to-end trade visibility and forms building blocks for further value creation in trade financing, product marketing, and data analytics.DiMuto is founded by executive chairman Mr Gary Loh, who is also the Executive Chairman of First Alverstone Group.
- Aevice Health — Meet our AeviceMD, all-in-one sensor to deliver hospital-quality insights, right from home.
- Mushroom Material — We can match the mechanical properties of polystyrene styrofoam and replace any existing packaging with a sustainable mushroom alternative
BIOCHING CAPITAL is an investment management firm.
Show more
Investment focus
- Medical Device, Medical, Biopharma
- Angel, Seed
- China
Portfolio highlights
- Weimai Medical — Weimai Medical is an all-inclusive resource for minimally invasive and non-invasive energy medicine solutions.
- Thorough Future — Using big data and artificial intelligence to provide pathology images with intelligent discriminations, diagnosis, prediction.
- Aoli Biotechnology — Aoli Biotechnology is a biopharmaceutical oral delivery technology provider. Aoli Biotechnology focuses on research into macromolecule oral delivery technology and has developed a number of world-leading excipient technology patents, including soteria and phloral technology.
They are an investment firm dedicated to support healthcare companies to generate robust and sustained growth prospect in China and to partner with entrepreneurs with dedication and the highest standard.
Show more
Investment focus
- Health Care, Biotechnology, Medical
- Series A, Series B, Seed
- China, United States, Portugal
Portfolio highlights
- EdgeRock — EdgeRock offers an automotive integrated brake-by-wire system. EdgeRock supplies highly integrated capabilities for big and heavy load technologies.
- Sieran Medical — Sieran Medical is a medical device company that provides precise and intelligent minimally invasive surgical treatment solutions for ophthalmology.
- ZhongQing Robot — Zhongqing Robotics is a leading developer of embodied intelligent robots, focusing on research and development, utilizing collaborative software and hardware innovation for full-stack technology.
Insight Capital is a venture capital firm focused on early-stage investment.
Show more
Investment focus
- Health Care, Medical, Biotechnology
- Series A, Series B, Series C
- China
Portfolio highlights
- Amity — Discover Amity, where we create digital solutions that help organizations, teams and individuals achieve more through technology and social innovation.
- Sieran Medical — Sieran Medical is a medical device company that provides precise and intelligent minimally invasive surgical treatment solutions for ophthalmology.
- Amity Solutions — Enterprise Chatbots, AI-based generative Chatbots, pre-built social features for apps and websites, and building blocks for employee experiences.
The University of Tokyo IPC is a company responsible for expanding the innovation ecosystem of the University of Tokyo. Accelerate global innovation from the University of Tokyo through three activities: start-up support, investment business, and corporate innovation support.It was established as a wholly-owned subsidiary of the University ofTokyo in 2016 with the enforcement of the revised law of the Industrial Competitiveness Enhancement Law, which is the basis law. The investment targets of the Todai IPC are venture companies that utilize the research results and human resources of the University of Tokyo, but they also make FOF (fund of funds) investments in funds managed by some private venture capital companies. In 2019, it started a consortium-type incubation program (University of Tokyo IPC 1stRound) to support the establishment and financing of Tokyo University-related ventures.
Show more
Investment focus
- Biotechnology, Medical, Manufacturing
- Series A, Funding Round, Series B
- Japan, United States, United Kingdom
Portfolio highlights
- Visban — Visban is a technology company that specializes in utilizing mmWave signals for connectivity both indoors and outdoors. Their primary focus is on providing reliable and fast network solutions that eliminate dead spots and offer uninterrupted connections. By utilizing mmWave signals, Visban can achieve this with fewer base stations, leading to moreenergy-efficient operations and extended battery life for mobile devices on their network.
- Trans-N — Trans-N aims to introduce advanced AI technologies, accelerating digital transformation and promoting its AI transformation. Trans-N offers management consulting, AI system development, and sales of AI-related products, including meeting minutes and contract analysis tools, serving major trading companies.
- Libero Thera — LiberoThera provides drug discovery research and development services. It focuses on making drugs with GPCRs for membrane proteins. LiberoThera was founded in 2018 and is located in Tokyo.
Prosperico Ventures is a venture capital firm focused on healthcare and the high-tech industry.
Show more
Investment focus
- Medical, Health Care, Biotechnology
- Series A, Series B, Seed
- China, United States
Portfolio highlights
- Cytocares — Cytocares offers innovative drug design for antibody novel medication creation and development in the realm of tumor immunity.
- KingstronBio — KingstronBio manufactures artificial heart valves and annuloplasty rings.
- Jiaohong Biology — Jiaohong Biology is a molecular diagnostic technology research and development and application service provider.
Cenova Capital is one of the earliest healthcare dedicated funds in China founded in 2010 by Dr Jun WU and is one of the earliest investors in private healthcare services and digital health, with helps to facilitate the transformation of healthcare in China from an exclusively state-owned system to a more efficient, market-oriented system. CenovaCapital is healthcare funds dedicated to early and growth-stage investments in the life sciences and healthcare sector in China. Since inception in 2010, Cenova now has five funds under management with investments in over 50 companies in healthcare services, pharmaceuticals, medical devices and digital heath. Cenova's investors are mainly large domestic and international institutional investors including Asian sovereign wealth funds, government institutions, insurance and financial institutions and multinational companies.
Show more
Investment focus
- Health Care, Medical, Biotechnology
- Series B, Series A, Series C
- China, Singapore, United States
Portfolio highlights
- Phage Pharm — Phage Pharm is a professional enterprise in the industrialization of bacteriophages.
- Agile Medical — Agile Medical, a surgical robot company, focuses on research, development, and industrialization of intelligent surgical products. Agile Medical's technology innovation platform covers mechanics, electronics, optics, computing, and software.
- Jiangsu Jland Biotech — Jiangsu Jland Biotech is dedicated to the development and production of Biollagen™ collagen and is determined to be the biggest non-animal-sourced collagen supplier worldwide.
SBI Investment supports the business development and growth of private venture companies through fund investment. It manages and manages venture capital funds under the management philosophy of becoming a leading company responsible for the creation and development of core industries in the 21st century as a "new industry creator".SBIInvestment has invested in a total of 986 companies in the past, of which 169 (17.1% of investment companies) have exited through IPO or M & A.
Show more
Investment focus
- Information Technology, Software, Financial Services
- Series B, Funding Round, Series A
- Japan, South Korea, United States
Portfolio highlights
- AironWorks — Next Gen Solutions for Human-Based Cyber Attacks
- Recustomer — Recustomer is an IT company that develops software for digital payment and provides support for web development.
- PartnerSuccess — PartnerSuccess develops and provides SaaS tools that automate the collaboration between manufacturers and distributors.
Yunnan Bethany Biotechnology is a healthcare company that manufactures skin care products for sensitive skin, acne, barrier damage, stubborn spots, and fragile skin. They provide a scientific care programs for certain skin problems and develop effective and safe skin care products.
Show more
Investment focus
- Medical, Medical Device, Health Care
- Series A, Corporate Round
- China
Portfolio highlights
- Weimu Medical — Weimu Medical is a high-end interventional medical device developer.
- Weimai Medical — Weimai Medical is an all-inclusive resource for minimally invasive and non-invasive energy medicine solutions.
- Ruishi Technology — Ruishi Technology develops Myopia prevention and control medical devices.
Supporting the next generation of entpreneurs in enterprise, healthcare, and consumer with disruptive potential.
Show more
Investment focus
- Medical, Health Care, Biotechnology
- Series A, Series B, Seed
- China, United States, South Korea
Portfolio highlights
- RootData — Providing the most up-to-date and complete Crypto project financing information,detailed project background,team members,investors,news updates,token price data,and on-chain assets tracking. Dedicated to making Crypto investing easier.
- Wanglitong — Wanglitong manufactures lithium battery auxiliary materials. It currently specializes on lithium battery films and membrane materials. Its current product lines include brown high-temperature tape, milky white OPP tape, and TPU expansion tape, all of which have reached mass production.
- Coordinate System Intelligence — Coordinate System Intelligence is a provider of automotive brake-by-wire system solutions. It focuses on providing core technology solutions.
Oriza Seed Venture Capital, located in Suzhou Industrial Park, is held by Suzhou Oriza Holdings Ltd. Oriza Seed is a market-oriented investment platform. It looks for investment opportunities among early-stage and growth-stage enterprises in the fields of Healthcare and TMT. Oriza Seed has ample resources and experiences investing in the healthcarefield. By late March 2016, Oriza Seed has invested in more than 50 healthcare companies, including Ascentage Pharma, Innovent Biologics, and SceneRay Corporation.
Show more
Investment focus
- Manufacturing, Health Care, Biotechnology
- Series A, Seed, Angel
- China, United States
Portfolio highlights
- Simnova — Simnova Biotherapeutics is a biopharmaceutical company that focuses on the research and development of cell therapies for cancer treatment. The company's primary therapeutic focus is CAR-based cell therapy for patients with either hematologic malignancies or solid tumors. Simnova Biotherapeutics is known for its innovative approach todeveloping patient-centered therapeutics using current science and technology. The company's lead product is SNC102, a cell therapy product that has been approved for clinical trials. Simnova Biotherapeutics is committed to creating a healthy, inclusive, and harmonious working environment.
- Xinhong life — Xinhong Life is a technologically creative medical company dedicated to developing a medical enterprise based on ultrasound energy technology as well as combining drug and device technology. Xinhong Life, which specializes in interventional ultrasound technology and combined drug-device technology, has developed a number of technology platforms,including interventional ultrasound energy technology, combined drug-device technology, software and algorithm architecture technology, and industrial transformation platforms, and continues to develop innovative energy device products that truly address clinical pain points.
- Agile Medical — Agile Medical, a surgical robot company, focuses on research, development, and industrialization of intelligent surgical products. Agile Medical's technology innovation platform covers mechanics, electronics, optics, computing, and software.
Chiron Ventures is an investment firm specializes in innovation and investment in medical health.Chiron Ventures has accumulated rich experience and resources in medical technology development, medical innovation and entrepreneurship, and medical market development, providing substantial support and professional value-added services for itsinvestment projects.
Show more
Investment focus
- Medical, Health Care, Medical Device
- Series A, Seed, Angel
- China, Australia, United States
Portfolio highlights
- Hicicare — Hicicare is a medical technology company that specializes in the development of pan-vascular interventional medical devices.
- Ren Labs — Empowering projects to create a limitless future for the decentralized web.
- Pulnovo Medical — Pulnovo Medical integrates development, production and services. Our core products including use pf radiofrequency ablation technology to treat pulmonary hypertension. The high-frequency ablation equipment and intravascular catheters developed by the company are pioneer inventions with global invention patents.
Green Pine Capital Partners is a venture capital firm.
Show more
Investment focus
- Artificial Intelligence, Manufacturing, Software
- Series A, Angel, Series B
- China, United States, Canada
Portfolio highlights
- Baisios — Baisios is a developer of tumor immune cell therapy technology and is dedicated to the growth of the tumor biotherapy industry.
- Neurogin — Neurogin is a bioelectronics company that provides reliable monitoring and auxiliary diagnostic tools for clinical and health institutions and focuses on advanced engineering methods for brain science research and clinical diagnosis.
- Jiangxing Intelligence — Jiangxing Intelligence was founded in 2018 by internationally renowned scientists, academician of the Canadian Academy of Engineering, and IEEE Fellow Professor Liu Jiangchuan. The company is committed to the development of advanced edge computing technology and its application in the fields of energy Internet, industrial security, and intelligentwarehousing. At the beginning of the company's establishment, it has obtained tens of millions of venture capital from Sequoia Capital China Seed Fund.
BGI Co-Win is the corporate venture capital arm of BGI and is based in Shenzhen, China.
Show more
Investment focus
- Biotechnology, Health Care, Medical Device
- Series A, Seed, Angel
- China
Portfolio highlights
- LeadBio Tech — LeadBio Tech is a biotechnology company that specializes in the development of bioartificial blood vessel medical devices.
- Yingshu Life — Yingshu Life is a research and development manufacturer of minimally invasive medical devices.
- Waker Biology — Weike Bio is a gene therapy drug development company.
Yuanhui Chuangyi is an investment firm.
Show more
Investment focus
- Medical Device, Beauty, Industrial
- Seed, Series A
- China
Portfolio highlights
- Toll PATEO — Toll PATEO is a natural science, medical research and experimental development service provider.
- Yuewei Medical — Yuewei Medical is a developer of cardiac surgery interventional medical devices.
- Xijian Technology — Xijian Technology is committed to advancing the industrialization of innovative human biomechanics imaging technology. It focuses on health disciplines such as sports rehabilitation, dermatology and beauty, and disease diagnosis and treatment.
Investors by industry
Energy
Climate
Health Care
Gaming
Hardware
Artificial intelligence
Impact
Proptech
Marketplace
Community
FinTech
Google
Consumer
Biotech
EdTech
Sustainability
Venture Capital
Beauty
B2B
Photography
Finance
Real Estate
Big Data
Web3
Clean Energy
Oil and Gas
Video Games
Food and Beverage
Publishing
Education
Payments
Fashion
Organic Food
Retail
Financial Services
Infrastructure
Social Media
Medical
Email
Art
Wellness
Music
Mobile
Franchise
Social Network
Local
Platforms
Mobile Advertising
Biotechnology
Internet
Hospitality
Fitness
Travel
Recruiting
Cannabis
Wine And Spirits
Digital Media
Medical Device
Crowdfunding
Social
Automotive
CleanTech
Transportation
Construction
Mobile Apps
InsurTech
Enterprise
Manufacturing
eSports
Sports
Enterprise Software
LGBT
Legal
Android
Life Science
Theatre
Film
Non Profit
SaaS
Renewable Energy
Sporting Goods
Software
Restaurants
Social Impact
Celebrity
Cryptocurrency
Media (entertainment)
Agriculture (agtech)
Facebook
Blockchain
Investors by country
India
Germany
South Korea
United Kingdom
Australia
Ireland
New Zealand
Canada
United States
Spain
Indonesia
Singapore
South Africa
Africa
Qatar
Europe
LATAM
Middle East
Sri Lanka
Asia
Armenia
Vietnam
China
Japan
Saudi Arabia
Brazil
Oceania
Czech Republic
Ecuador
Barbados
Costa Rica
Finland
Belarus
France
Estonia
Hong Kong
Denmark
Gibraltar
Chile
Bermuda
Belize
Georgia
Greece
Egypt
Hungary
Ethiopia
Faroe Islands
Algeria
Ghana
Belgium
Croatia
Bulgaria
Bahrain
Morocco
Malta
Mali
Malaysia
Turkey
Serbia
Italy
Rwanda
Peru
El Salvador
Venezuela
Ukraine
Lithuania
Portugal
Sierra Leone
Myanmar
Zimbabwe
Sweden
Lebanon
Kuwait
Taiwan
Cayman Islands
Senegal
Cambodia
Israel
Panama
Uruguay
Uganda
Mexico
Tunisia
San Marino
Kazakhstan
Slovenia
Liberia
Jersey
Zambia
Philippines
Uzbekistan
Russian Federation
Norway
Seychelles
Thailand
Mauritius
Puerto Rico
Kenya
Tajikistan
Togo
Poland
Liechtenstein
Tanzania
Nicaragua
Dominican Republic
United Arab Emirates
Nigeria
Honduras
Azerbaijan
Namibia
Bolivia
Iceland
Isle of Man
Iraq
Bahamas
Luxembourg
Albania
Pakistan
Grenada
Jordan
Romania
Argentina
Bangladesh
Guatemala
Latvia
Cyprus
Oman
Austria
Cameroon
Switzerland
Colombia
Marshall Islands
Investors in Asia by industry
Restaurants
Crowdfunding
Venture Capital
Film
Mobile Advertising
B2B
Mobile Apps
Cryptocurrency
Finance
Payments
Food and Beverage
Video Games
Wine And Spirits
Medical Device
Internet
Email
Social Media
Social Network
Digital Media
Manufacturing
Art
Mobile
Android
Google
Local
Construction
Software
Sports
Enterprise Software
Legal
eSports
Fitness
CleanTech
Automotive
Hospitality
Travel
Recruiting
Platforms
FinTech
Biotechnology
Enterprise
Consumer
Real Estate
Biotech
Impact
Climate
Health Care
Energy
Sustainability
SaaS
Marketplace
Hardware
Proptech
Community
Gaming
Social Impact
Social
Retail
Infrastructure
Fashion
Beauty
Web3
Photography
Sporting Goods
Publishing
Big Data
Medical
Renewable Energy
Clean Energy
Financial Services
Oil and Gas
Transportation
Non Profit
Wellness
Blockchain
EdTech
Education
Media (entertainment)
Franchise
Life Science
Music
Agriculture (agtech)
Organic Food
InsurTech
Artificial intelligence